Physician profile
Tracy B Wright
NPI 1629088893
$1,248.00
in general payments reported to CMS, 2019-2025
27 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $31.19 · 2022: $303 · 2023: $224 · 2024: $148 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $233.93 | 2019-2022 | |
| Astellas Pharma US INC | $94.83 | 2023-2025 | Veozah |
| Organon LLC | $87.34 | 2022-2025 | Nexplanon |
| Myriad Women'S Health, INC. | $77.98 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $61.51 | 2019-2024 | Myosure Tissue Removal Device, Novasure |
| Exeltis, USA INC. | $61.11 | 2023-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $59.83 | 2019-2025 | |
| Aspira Women'S Health INC | $44.68 | 2022-2023 | Ova1 |
| Daiichi Sankyo INC. | $44.08 | 2019-2022 | |
| Karl Storz Endoscopy-America | $43.38 | 2022 | |
| Minerva Surgical, INC | $42.90 | 2019 | |
| Channel Medsystems, INC. | $40.50 | 2022 | |
| Alexion Pharmaceuticals, INC. | $37.00 | 2019 | |
| Biogen, INC. | $34.86 | 2024 | |
| Pfizer INC. | $34.58 | 2022-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $33.65 | 2019-2025 | Ally II Ups |
| Scynexis, INC. | $32.35 | 2022 | |
| Merck Sharp & Dohme LLC | $26.14 | 2019-2020 | |
| Innovation Technologies INC | $25.87 | 2025 | Irrisept |
| Myovant Sciences INC. | $21.26 | 2022 | |
| Mylan Pharmaceuticals INC. | $19.62 | 2019 | |
| Ethicon US, LLC | $17.99 | 2022 | |
| Lilly USA, LLC | $17.45 | 2024 | Zepbound |
| Millicent US INC | $16.51 | 2025 | Intrarosa, Femlyv |
| Meditrina | $14.13 | 2024 | |
| Vertical Pharmaceuticals, LLC | $12.82 | 2019 | |
| Avion Pharmaceuticals | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.